Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Return on Equity: 2015-2023

Historic Return on Equity for Cellectis (CLLS) over the last 8 years, with Sep 2023 value amounting to -2.32%.

  • Cellectis' Return on Equity rose 1754.00% to -2.32% in Q3 2023 from the same period last year, while for Sep 2023 it was -2.32%, marking a year-over-year increase of 1754.00%. This contributed to the annual value of -17.12% for FY2022, which is 1694.00% down from last year.
  • As of Q3 2023, Cellectis' Return on Equity stood at -2.32%, which was up 87.73% from -18.93% recorded in Q2 2023.
  • Cellectis' Return on Equity's 5-year high stood at -0.26% during Q2 2020, with a 5-year trough of -19.86% in Q3 2022.
  • For the 3-year period, Cellectis' Return on Equity averaged around -4.34%, with its median value being -1.11% (2022).
  • As far as peak fluctuations go, Cellectis' Return on Equity tumbled by 3,136bps in 2019, and later surged by 1,754bps in 2023.
  • Over the past 5 years, Cellectis' Return on Equity (Quarterly) stood at -0.70% in 2019, then soared by 41bps to -0.29% in 2020, then dropped by 19bps to -0.48% in 2021, then slumped by 108bps to -1.55% in 2022, then spiked by 1,754bps to -2.32% in 2023.
  • Its Return on Equity was -2.32% in Q3 2023, compared to -18.93% in Q2 2023 and -1.55% in Q1 2023.